metastatic hormone refractory

Related by string. * Metastatic : metastatic prostate cancer . metastatic pancreatic cancer . metastatic lesions . metastatic colorectal cancer / hormones . Hormone . Hormones : Hormone Replacement Therapy . Human Growth Hormone . male hormone testosterone / Refractory : relapsed refractory multiple myeloma . refractory Hodgkin lymphoma . hormone refractory prostate cancer * *

Related by context. Frequent words. (Click for all words.) 74 HER2 positive metastatic breast 72 relapsed refractory multiple myeloma 72 plus prednisone 71 hormone refractory prostate cancer 71 pertuzumab 71 Jevtana 71 castration resistant prostate cancer 71 Amrubicin 70 Nexavar ® 70 relapsed multiple myeloma 70 refractory multiple myeloma 70 metastatic renal cell carcinoma 68 Taxotere ® 68 temsirolimus 68 FOLFIRI 68 Bevacizumab 68 abiraterone acetate 68 Irinotecan 68 tanespimycin 68 Pirfenidone 67 Asentar 67 dacarbazine 67 IMC A# 67 romidepsin 67 Torisel 67 CR# vcMMAE 67 HRPC 67 cabazitaxel 67 BAY #-# 67 Pivotal Phase 66 active comparator 66 methylnaltrexone 66 plus dexamethasone 66 MDV# 66 Erlotinib 66 Phase 2a trial 66 Gemcitabine 66 tocilizumab 66 Pivotal Phase III 66 docetaxel 66 CoFactor 65 Laquinimod 65 abiraterone 65 axitinib 65 nab paclitaxel 65 Phase 1b trial 65 HGS ETR1 65 phase IIb 65 vandetanib 65 XELOX 65 aflibercept 65 Hycamtin 65 Cloretazine R VNP#M 65 phase IIa 65 ELND# 65 registrational trial 65 cutaneous T cell 65 ARIMIDEX 65 mycophenolate mofetil 65 interferon alfa 65 Phase 1b 65 KNS # 65 androgen independent 65 Camptosar 65 Phase III Clinical Trial 65 Voreloxin 65 GVAX immunotherapy 65 Phase IIa trial 65 Lenalidomide 64 peginterferon alfa 2b 64 decitabine 64 Pivotal Trial 64 thymalfasin 64 Navelbine 64 glufosfamide 64 non squamous 64 SCH # 64 TYKERB 64 registrational 64 Bortezomib 64 ZYBRESTAT 64 Phase Ib 64 Avastin bevacizumab 64 plus gemcitabine 64 Mylotarg 64 Phase 2b trial 64 talabostat 64 neoadjuvant 64 diabetic neuropathic pain 64 ThermoDox ® 64 Sorafenib 64 cangrelor 64 pivotal Phase III 64 lymphoma CTCL 64 Trastuzumab 64 EGFR expressing metastatic colorectal 64 REVLIMID ® 64 Phase III Trial 64 monotherapy 64 tesmilifene 63 Combination therapy

Back to home page